| Principles and choice of agents | Pare Bardera J C (Barcelona, ES) | Contrast Basics |
| Contrast for optimal border detection | Hoffmann R (Aachen, DE) | Contrast LVO |
| How to perform stress echo with contrast | Becher H H (Oxford, GB) | Contrast How to |
| Rest contrast echo for ischemia and viability | Vanoverschelde J-L (Brussels, BE) | Contrast Ischemia/viability |
| Differentiate hypertrophic cardiomyopathy from athlete’s heart | Ribeiras R (Cascais -Lisbon, PT) | Athletes heart vs HCM |
| Detect abnormal origin of the coronary arteries and early-onset atherosclerosis | Fiuza M M (Lisbon, PT) | Coronary anomaly |
| Prevent sudden death in athletes by preparticipation screening in 2007: should this athlete be disqualified? | D'Andrea A (Naples, IT) | Sudden death |
| Treat sudden death in athletes: the recovery of broken hearts! | Andrade M J (Lisboa, PT) | Sudden death |
| Edler Lecture 2007 Echo Odyssey: A journey into the secrets of the heart | Pinto F J (Lisbon, PT) | Pinto's Edler lecture |
| Engineering of microbubbles. Which one to choose? | Agati L (Rome, IT) | Contrast Microbubbles |
| For left ventricular volumes and function | Hoffmann R (Aachen, DE) | Contrast LV function |
| For valve disease and cardiac shunts | Ten Cate F J (Rotterdam, NL) | Contrast Cardioembolic disease |
| Evaluation of microcirculation | Kaul S (Portland, US) | Contrast Microcirculation |
| Contrast perfusion during stress | Zoghbi W A (Houston, US) | Contrast Stress |
| The next step: automated quantification of perfusion and contrast without stress for detecting ischaemia | Agati L (Rome, IT) | Contrast Quantification of perfusion |
| Cost-effectiveness of contrast in stress echo | DeMaria A (San Diego, US) | Contrast costs |
| Contrast echocardiography in coronary heart disease diagnosis: a comparison with CMR and multislice CT | Ito H (Osaka, JP) | Contrast, CAD diagnose vs CT |
| Assessment of myocardial blood volume and its relationship to blood flow | Yamada S (Sapporo, JP) | Contrast to assess MBF |
| Evaluation of patients with chronic coronary heart disease after coronary events or interventions | Kamp O (Amsterdam, NL) | Contrast in chronic CAD |
| Basics of molecular imaging using contrast | Aguilar Torres R J (Barcelona, ES) | Contrast, molecular imaging |
| Targeted microbubbles for atherosclerosis | DeMaria A (San Diego, US) | Contrast, Future |
| Thrombus targeting | Lindner J R (Portland, US) | Contrast, targeting thrombus |
| Vasa vasorum imaging | Feinstein S B (Chicago, US) | Preventive cardiology |
| Imaging the vulnerable plaque: virtual histology | Weissman N (Washington, US) | Vulnerable plaque |
| What do the guidelines say? Do I need echocardiography? A view from the electrophysiologist | Gasparini M (Rozzano, IT) | CRT, EP point of view |
| The only proven criteria are NYHA and QRS duration. Why is delayed electrical activation important in heart failure? | Mont L (Barcelona, ES) | CRT Identifyin candidates |
| Is there any role for other imaging modalities? | Ajmone Marsan N (Leiden, NL) | CRT, other imaging modalities |
| QRS duration is enough to assess the correct programming of the device during follow-up | Kautzner J (Prague, CZ) | CRT, QRS is enough |
| Echocardiography is necessary to optimise the AV and the VV times: a practical point of view | Bax J J (Leiden, NL) | CRT, AV & VV optimization |
| Follow-up should be performed jointly by heart rhythm specialists, heart failure specialists and echocardiographers | Merino J L (Madrid, ES) | CRT, follow-up |
| Reverberations and the apex: people and innovative [echo] technology changing lives | Martin R (Atlanta, US) | EuroEcho lecture: Present & Future of echo &EAE |
| Tips and Tricks (mini lecture) | Mele D (Marina Di Ravenna, IT) | CRT, identifying responders |
| Tips and Tricks (mini lecture) | Yu CM (Hong Kong, HK) | CRT, optimization AV interval |
| How to implement 3D into the echocardiography lab. | Badano L (Udine, IT) | 3D, basics |
| Improved assessment of global and regional function with 3D echocardiography. | Hung J (Boston, US) | 3D, LV function |
| 3D echocardiography in congenital heart disease. | Marx G (Boston, US) | 3D congenital |
| What is next with 3D echocardiography? 3D TEE and more. | Lang R M (Chicago, US) | 3D, Future |
| The EAE accreditation experience: what we learned. | Popescu B A (Bucharest, RO) | Accreditation |
| Digital laboratories: do they improve quality? | Badano L (Udine, IT) | Dig-Echo lab |
| The spread of the culture of accreditation in Europe. | Hagendorff A (Leipzig, DE) | Accreditation in Europe |
| Training, individual and laboratory accreditation. | Nihoyannopoulos P (London, GB) | Accreditation |
| Preparing for the EAE accreditation process written exam. Advice for supervisors and applicants. | Pinto F J (Lisbon, PT) | How to prepare accreditation exam |
| Writing effective echocardiography reports for your colleagues and for the EAE accreditation Log Book Markers. | Kneeshaw J D (Cambridge, GB) | Echo reports |
| Maintaining competence in echocardiography. Continuing education and skill development. | Fox K F (London, GB) | Maintaning competence |